PROCEPT BioRobotics Corporation stock rating and score history
All changes in ratings, performance and outlook tracked over time.
PROCEPT BioRobotics Corporation stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does PROCEPT BioRobotics Corporation do? Business model and key facts
Get the full picture of PROCEPT BioRobotics Corporation: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Medical - Devices
Employees (FY): 888
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
Stocks related to PROCEPT BioRobotics Corporation
Selected based on industry alignment and relative market positioning.
Events and news impacting PROCEPT BioRobotics Corporation stock
Earnings, coporate decisions and industry developments that can affect the share price.
PROCEPT BioRobotics Corporation fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
